Medical Management of Acute Rhinosinusitis

  • Richard R. OrlandiEmail author

Broadly defined, acute rhinosinusitis is an inflammatory condition of the nose and paranasal sinuses lasting up to 4 weeks [1]. This straightforward definition does not take into account etiology, which is typically, but not always, infectious. Viruses and bacteria are the most common causes of acute rhinosinusitis, with both resulting from, as well as causing, mucosal thickening and trapped mucous secretions. As a result of the upper and lower airways typically reacting in concert, lower airway inflammation may also be a feature of acute upper airway inflammation. Treatment of acute rhinosinusitis, therefore, is aimed not only at causative organisms, but also at the associated inflammation and resulting symptoms.

Chronic rhinosinusitis, defined as symptoms lasting longer than 12 weeks, is a condition separate from acute rhinosinusitis in etiology and pathophysiology. The syndrome of chronic rhinosinusitis appears to be a primarily inflammatory condition, with intermittent acute...


Acute Exacerbation Chronic Rhinosinusitis Macrolide Antibiotic Ipratropium Bromide Moraxella Catarrhalis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129(3 suppl):S1–S32.PubMedCrossRefGoogle Scholar
  2. 2.
    Ferguson BJ. Definitions of fungal rhinosinusitis. Otolaryngol Clin N Am 2000;33(2): 227–235.CrossRefGoogle Scholar
  3. 3.
    Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996;23(6):1209–1223; quiz 1224–1225.PubMedCrossRefGoogle Scholar
  4. 4.
    Orlandi RR, Kennedy DW. Surgical management of rhinosinusitis. Am J Med Sci 1998;316(1):29–38.PubMedCrossRefGoogle Scholar
  5. 5.
    Gwaltney JM Jr, Hendley JO, Phillips CD, et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000;30(2):387–391.PubMedCrossRefGoogle Scholar
  6. 6.
    Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002;89(3): 271–278.PubMedCrossRefGoogle Scholar
  7. 7.
    Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92(6):812–823.PubMedCrossRefGoogle Scholar
  8. 8.
    Yilmaz G, Varan B, Yilmaz T, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Eur Arch Otorhinolaryngol 2000;257(5):256–259.PubMedCrossRefGoogle Scholar
  9. 9.
    Meltzer EO, Charous BL, Busse WW, et al. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol 2000;106(4):630–637.PubMedCrossRefGoogle Scholar
  10. 10.
    Dolor RJ, Witsell DL, Hellkamp AS, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA 2001;286(24):3097–3105.PubMedCrossRefGoogle Scholar
  11. 11.
    Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289–1295.PubMedCrossRefGoogle Scholar
  12. 12.
    Rhee CS, Majima Y, Arima S, et al. Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. Ann Otol Rhinol Laryngol 2000;109(5): 484–487.PubMedGoogle Scholar
  13. 13.
    Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004;125(2 suppl):52S–60S; quiz 60S–61S.Google Scholar
  14. 14.
    Wallwork B, Coman W, Mackay-Sim A, et al. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope 2004;114(2):286–290.PubMedCrossRefGoogle Scholar
  15. 15.
    Wallwork B, Coman W, Feron F, et al. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 2002;112:1827–1830.PubMedCrossRefGoogle Scholar
  16. 16.
    Bishai WR. Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin. Expert Rev Anti Infect Ther 2006;4(3):405–416.PubMedCrossRefGoogle Scholar
  17. 17.
    Axelsson A, Jensen C, Melin O, et al. Treatment of acute maxillary sinusitis. V. Amoxicillin azidocillin, phenylpropanolamine and pivampicillin. Acta Otolaryngol 1981;91(3-4): 313–318.PubMedCrossRefGoogle Scholar
  18. 18.
    McCormick DP, John SD, Swischuk LE, et al. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996;35(9):457–460.CrossRefGoogle Scholar
  19. 19.
    Bende M, Fukami M, Arfors KE, et al. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit. Ann Otol Rhinol Laryngol 1996;105(3):222–225.PubMedGoogle Scholar
  20. 20.
    Inanli S, Ozturk O, Korkmaz M, et al. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo. Laryngoscope 2002;112(2): 320–325.PubMedCrossRefGoogle Scholar
  21. 21.
    Orlandi RR. Biopsy and specimen collection in chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004;193:24–6.PubMedGoogle Scholar
  22. 22.
    Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(1 suppl):1–45.PubMedGoogle Scholar
  23. 23.
    Acute rhinosinusitis in adults. 2005 [cited 2007]. Available from: pdf/guideline/rhino05.pdf.
  24. 24.
    Marple BF, Brunton S, Ferguson BJ. Acute bacterial rhinosinusitis: a review of U.S. treatment guidelines. Otolaryngol Head Neck Surg 2006;135(3):341–348.PubMedCrossRefGoogle Scholar
  25. 25.
  26. 26.
    Acute Bacterial Sinusitis Guideline Team CCsHMC. Evidence-based care guideline for management of acute bacterial sinusitis in children 1–17 years of age. 2006 [cited]. Available from:
  27. 27.
    Snow V, Mottur-Pilson C, Hickner JM. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001;134(6):495–497.PubMedGoogle Scholar
  28. 28.
    Ip S, Fu L, Balk E, et al. Update on Acute Bacterial Rhinosinusitis. Evidence Report/ Technology Assessment No. 124. (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022). AHRQ Publication No. 05-E020-2. 2005. Agency for Healthcare Research and Quality, Rockville, MD.Google Scholar
  29. 29.
    Poole MD. A mathematical therapeutic outcomes model for sinusitis. Otolaryngol Head Neck Surg 2004;130(1 suppl):46–50.PubMedCrossRefGoogle Scholar
  30. 30.
    Vogan JC, Bolger WE, Keyes AS. Endoscopically guided sinonasal cultures: a direct comparison with maxillary sinus aspirate cultures. Otolaryngol Head Neck Surg 2002;122(3): 370–373.CrossRefGoogle Scholar
  31. 31.
    Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: developing guidance for clinical trials. Otolaryngol Head Neck Surg 2006;135(5 suppl):S31–S80PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Division of Otolaryngology – Head and Neck SurgeryUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations